Treace Medical Concepts (TMCI) Enterprise Value (2020 - 2026)

Treace Medical Concepts has reported Enterprise Value for 7 years, with the latest figure at -$51.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 31.85% year-over-year to -$51.9 million; the trailing twelve-month figure through Mar 2026 stood at -$51.9 million (up 31.85% YoY), and the FY2025 full-year result was -$48.4 million, up 36.09% from the prior year.
• Enterprise Value for Q1 2026 stood at -$51.9 million, down from -$48.4 million in the prior quarter.
• The five-year high for Enterprise Value was -$48.4 million in Q4 2025, with the low at -$170.7 million in Q1 2023.
• Historically, Enterprise Value has averaged -$94.0 million across 5 years, with a median of -$88.9 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value plunged 507.25% — and 2024, when it soared 38.57%.
• Treace Medical Concepts' Enterprise Value stood at -$81.3 million in 2022, then slumped by 51.62% to -$123.2 million in 2023, then soared by 38.57% to -$75.7 million in 2024, then soared by 36.09% to -$48.4 million in 2025, then decreased by 7.21% to -$51.9 million in 2026.
• The last three Enterprise Value figures came in at -$51.9 million (Q1 2026), -$48.4 million (Q4 2025), and -$57.4 million (Q3 2025), per Business Quant data.